Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxalt (Rizatriptan) for Early Treatment of Mild Migraine Attacks
NCT00095004Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rizatriptan in migraine, sponsored by Organon & Co.. Started Oct 2004; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00095004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095004.